Terms: = Ovarian cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626
168 results:
1. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
[TBL] [Abstract] [Full Text] [Related]
2. Mixed ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
Chui MH; Ellenson LH
Am J Surg Pathol; 2023 Jul; 47(7):756-765. PubMed ID: 37125505
[TBL] [Abstract] [Full Text] [Related]
3. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic Features and the Loss of ARID1A Expression in ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
5. Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma.
Arciuolo D; Travaglino A; Santoro A; Pedone Anchora L; Inzani F; Angelico G; D'Alessandris N; Scaglione G; Valente M; Raffone A; Fanfani F; Zannoni GF
Int J Gynecol Pathol; 2022 Nov; 41(6):583-587. PubMed ID: 36302189
[TBL] [Abstract] [Full Text] [Related]
6. Isolated Metastasis to Fallopian Tube Mucosa by Low-Grade Appendiceal Mucinous Neoplasm: Report of Two Cases.
Siatecka H; Al-Awami S; Masand RP
Int J Surg Pathol; 2023 Aug; 31(5):646-650. PubMed ID: 35946118
[TBL] [Abstract] [Full Text] [Related]
7. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
8. A comprehensive look into the association of vitamin D levels and vitamin D receptor gene polymorphism with obesity in children.
Akter R; Afrose A; Sharmin S; Rezwan R; Rahman MR; Neelotpol S
Biomed Pharmacother; 2022 Sep; 153():113285. PubMed ID: 35728355
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological observation of mature teratoma with malignant transformation, a single center retrospective study.
Yuan Y; Li H; Yang H
Indian J Pathol Microbiol; 2022; 65(2):369-373. PubMed ID: 35435373
[TBL] [Abstract] [Full Text] [Related]
10. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E
J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670
[TBL] [Abstract] [Full Text] [Related]
11. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.
Ponzini F; Kowal L; Ghafoor M; Goldberg A; Chan J; Lamm R; Cannaday SM; Richard SD; Nevler A; Lavu H; Bowne WB; Rosenblum NG
World J Surg Oncol; 2022 Mar; 20(1):78. PubMed ID: 35272690
[TBL] [Abstract] [Full Text] [Related]
12. Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy.
Anderson KG; Oda SK; Bates BM; Burnett MG; Rodgers Suarez M; Ruskin SL; Greenberg PD
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264436
[TBL] [Abstract] [Full Text] [Related]
13. Intestinal-type mucinous ovarian carcinoma arising from a seromucinous precursor lesion.
Santoro A; D'Alessandris N; Travaglino A; Arciuolo D; Inzani F; Angelico G; Scaglione G; Valente M; Raffone A; Zannoni GF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1263-1267. PubMed ID: 35253183
[TBL] [Abstract] [Full Text] [Related]
14. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
Kaur K; Shah A; Gandhi J; Trivedi P
J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
[TBL] [Abstract] [Full Text] [Related]
15. A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
Chelariu-Raicu A; Holley E; Mayr D; Klauschen F; Wehweck F; Rottmann M; Kessler M; Kaltofen T; Czogalla B; Trillsch F; Mahner S; Schmoeckel E
Int J Gynecol Cancer; 2022 May; 32(5):662-668. PubMed ID: 35185017
[TBL] [Abstract] [Full Text] [Related]
16. Unusual ovarian Tumors With Endometrioid Proliferations Co-Expressing Estrogen Receptor and CDX-2 Arising in Cystadenofibromatous Background: Report of 3 Cases.
McMullen-Tabry ER; Sciallis AP; Udager AM; Skala SL
Int J Gynecol Pathol; 2023 Jan; 42(1):93-100. PubMed ID: 35149615
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Approach to Neuroendocrine Neoplasm Associated With ovarian Teratoma.
Opalińska M; Sowa-Staszczak A; Olearska H; Ulatowska-Bialas M; Gilis-Januszewska A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2021; 12():770266. PubMed ID: 34917031
[TBL] [Abstract] [Full Text] [Related]
18. Accurate Distinction of ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
Rodriguez M; Kang EY; Farrington K; Cook LS; Le ND; Karnezis AN; Lee CH; Nelson GS; Terzic T; Lee S; Köbel M
Am J Surg Pathol; 2021 Nov; 45(11):1452-1463. PubMed ID: 34534137
[TBL] [Abstract] [Full Text] [Related]
19. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic Pitfalls Related to Morular Metaplasia in Endometrioid Carcinoma: An Underestimated Issue.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Zullo F; Insabato L
Pathobiology; 2021; 88(3):261-266. PubMed ID: 33887731
[TBL] [Abstract] [Full Text] [Related]
[Next]
